Specific effervescent tablet against candida albicans IgY

A technology of Candida albicans and effervescent tablets, applied in the directions of antifungal agents, antibodies, sexually transmitted diseases, etc., can solve the problems of increased adhesion activity, unsalable products, dampness of sanitary napkins, etc., so as to reduce the toxic and side effects of drugs and make the drugs effective. Quick and antibacterial effect

Inactive Publication Date: 2009-05-06
杜木根
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

According to reports, among all vulvovaginal inflammations in the United States, the incidence rate of vulvovaginal candidiasis (VVC) is the highest, about 39%, and the main pathogenic bacteria is Candida albicans, accounting for more than 85%-90%, about 3 / 4 Women of childbearing age have suffered from VVC at least once, of which 16% have one attack, 84% have a second attack, and 35% have a second attack for more than six times. The increase in the sugar content of the mucous membrane provides sufficient carbon sources for the growth and budding of Candida. A more complex mechanism may be that estrogen increases the adhesion activity of vaginal epithelial cells to Candida and promotes the formation of yeast hyphae; 2. Contraceptives : The application of oral contraceptives containing high estrogen can increase the vaginal colonization rate of Candida, and the mechanism is the same as pregnancy; 3. Diabetes; 4. Simultaneous application of multiple broad-spectrum antibiotics can lead to flora imbalance, decreased immunity, and infection
5. Other factors: women's sanitary napkins are widely used, and the current sanitary napkin manufacturers gather, and the products are unsalable. In addition, buyers often buy large quantities for long-term storage for convenience and economy, resulting in moisture in sanitary napkins and even the outer packaging. damaged

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] Antibody titer>1:2600 specific anti-Candida albicans IgY 10mg

[0031] Boric acid 60mg

[0032] Sodium bicarbonate 50mg

[0033] Starch 30mg

[0034] Microcrystalline Cellulose 130mg

[0035] Sodium Lauryl Sulfate 3mg

[0036] Talc powder 30mg

[0037] Preparation method: Weigh 500mg of specific anti-Candida albicans IgY with antibody titer >1:2600, 3000mg of boric acid, 2500mg of sodium bicarbonate, 1500mg of starch, 6.5g of microcrystalline cellulose, 150mg of sodium lauryl sulfate, talcum powder 1500mg, respectively crushed and passed through a 20-mesh sieve. Part of the starch is mixed with boric acid and sodium bicarbonate respectively, and finally mixed with the main drug and other auxiliary materials, and directly compressed into tablets to obtain 50 tablets in total.

[0038] The specific anti-Candida albicans IgY effervescent tablet vaginal deep administration 1 tablet / day that above-mentioned embodiment is obtained, consecutive five days is a small cours...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A vaginal IgY effervescent tablet specifically to kill Candida albicans for treating mycotic vaginitis of woman, even if gravida and puerpera, is disclosed.

Description

technical field [0001] The invention relates to the application of a biological preparation belonging to chicken yolk immunoglobulin (IgG, IgY) products, in particular to specific anti-Candida albicans IgY effervescent tablets. Background technique [0002] In the past ten years, the research and application of IgY has been a hot topic and a very active topic in the field of immunology. Since the discovery of IgY by Williams (1962) abroad, the IgY that has been successfully prepared includes: anti-rotavirus IgY, anti-influenza virus IgY, anti-respiratory syncytial virus IgY, anti-Echinococcus granulosus IgY, anti-RNA polymerization Enzyme IgY, anti-human IgG IgY, anti-prostaglandin IgY, anti-thyroid hormone IgY, anti-insulin receptor IgY, anti-snake venom IgY, anti-scorpion venom IgY, etc. Although this domestic research started relatively late, anti-rotavirus IgY, anti-poliovirus IgY, anti-gastric cancer cell IgY, anti-HP IgY, anti-caries IgY, etc. have been prepared, and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K39/395A61K9/20A61K9/46A61P15/02A61P31/10
Inventor 傅颖媛
Owner 杜木根
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products